Protalix BioTherapeutics
PLX
#8897
Rank
S$0.18 B
Marketcap
S$2.27
Share price
1.14%
Change (1 day)
-6.14%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$37.67 Million

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are S$37.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$41.05 M-38.88%
2023-12-31S$67.17 M-24.56%
2022-12-31S$89.05 M-17.35%
2021-12-31S$0.10 B-14.24%
2020-12-31S$0.12 B-19.46%
2019-12-31S$0.15 B0.16%
2018-12-31S$0.15 B14.54%
2017-12-31S$0.13 B1.9%
2016-12-31S$0.13 B9.22%
2015-12-31S$0.12 B-30.97%
2014-12-31S$0.17 B-0.41%
2013-12-31S$0.17 B77.06%
2012-12-31S$0.10 B-0.48%
2011-12-31S$0.10 B2.96%
2010-12-31S$97.96 M-15.71%
2009-12-31S$0.11 B1157.29%
2008-12-31S$9.24 M44.3%
2007-12-31S$6.4 M54.51%
2006-12-31S$4.14 M120.38%
2005-12-31S$1.88 M1524.33%
2004-12-31S$0.11 M-13.51%
2003-12-31S$0.13 M-2.39%
2002-12-31S$0.13 M-4.09%
2001-12-31S$0.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amicus Therapeutics
FOLD
S$0.81 B 2,074.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.61 B 4,199.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$148.41 B 393,805.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.84 B 110,957.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel